Your browser doesn't support javascript.
loading
Cardiovascular disease management in people with diabetes outside North America and Western Europe in 2006 and 2015.
Tabesh, M; Magliano, D J; Tanamas, S K; Surmont, F; Bahendeka, S; Chiang, C-E; Elgart, J F; Gagliardino, J J; Kalra, S; Krishnamoorthy, S; Luk, A; Maegawa, H; Motala, A A; Pirie, F; Ramachandran, A; Tayeb, K; Vikulova, O; Wong, J; Shaw, J E.
Afiliação
  • Tabesh M; Baker Heart and Diabetes Institute, Melbourne, Australia.
  • Magliano DJ; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Tanamas SK; Baker Heart and Diabetes Institute, Melbourne, Australia.
  • Surmont F; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Bahendeka S; Baker Heart and Diabetes Institute, Melbourne, Australia.
  • Chiang CE; AstraZeneca, London, UK.
  • Elgart JF; MKPGMS-Uganda Martyrs University & St. Francis Hospital Nsambya, Kampala, Uganda.
  • Gagliardino JJ; General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Kalra S; CENEXA. Centro de Endocrinología Experimental y Aplicada (UNLP-CONICET), La Plata, Argentina.
  • Krishnamoorthy S; CENEXA. Centro de Endocrinología Experimental y Aplicada (UNLP-CONICET), La Plata, Argentina.
  • Luk A; Bharti Research Institute of Diabetes & Endocrinology, Bharti Hospital, Karnal, Haryana, India.
  • Maegawa H; Dr A Ramachandran's Diabetes Hospitals, Chennai, India.
  • Motala AA; Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong SAR, China.
  • Pirie F; Shiga University of Medical Science, Shiga, Japan.
  • Ramachandran A; Department of Diabetes and Endocrinology, University of KwaZulu Natal, Durban, South Africa.
  • Tayeb K; Department of Diabetes and Endocrinology, University of KwaZulu Natal, Durban, South Africa.
  • Vikulova O; Dr A Ramachandran's Diabetes Hospitals, Chennai, India.
  • Wong J; Diabetes Center at AlNoor Specialist Hospital, Makkah, Saudi Arabia.
  • Shaw JE; FGBU 'Endocrinology Research Center', Ministry of Health, Moscow, Russia.
Diabet Med ; 36(7): 878-887, 2019 07.
Article em En | MEDLINE | ID: mdl-30402961
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Diabetes Mellitus Tipo 2 / Angiopatias Diabéticas / Dislipidemias / Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Guideline Limite: Aged / Female / Humans / Male / Middle aged País como assunto: America do norte / Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Diabetes Mellitus Tipo 2 / Angiopatias Diabéticas / Dislipidemias / Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Guideline Limite: Aged / Female / Humans / Male / Middle aged País como assunto: America do norte / Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article